May 15 (Reuters) - Getinge AB GETIb.ST :
* GETINGE CEO ON ACUTE CARE THERAPIES UNIT: PROJECTS ORGANIC
GROWTH IN NET SALES OF 3-5% IN 2024-2028
* GETINGE CEO ON LIFE SCIENCE UNIT: PROJECTS ORGANIC GROWTH
IN NET
SALES OF 6-10% IN 2024-2028
* GETINGE CEO ON SURGICAL WORKFLOWS UNIT: PROJECTS ORGANIC
GROWTH
IN NET SALES OF 4-6% IN 2024-2028
* GETINGE CFO SEES ACUTE CARE THERAPIES ADJUSTED EBITA
MARGIN IN
LOW-TO-MID 20S AT END OF 2024-2028 PERIOD
* GETINGE CFO ON COST VERSUS PRICING DEVELOPMENT: SEES
COMPARATIVELY GOOD PRICING TRACTION COMPARED TO PEERS
Source text for Eikon: ID:
Further company coverage: GETIb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))